- Home
- ARCT vs NB Comparison
ARCT vs NB Comparison
Compare ARCT & NB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- NB
- Stock Information
- Founded
- ARCT 2013
- NB 1987
- Country
- ARCT United States
- NB United States
- Employees
- ARCT N/A
- NB N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- NB Metal Mining
- Sector
- ARCT Health Care
- NB Basic Materials
- Exchange
- ARCT Nasdaq
- NB Nasdaq
- Market Cap
- ARCT 320.8M
- NB 292.8M
- IPO Year
- ARCT N/A
- NB N/A
- Fundamental
- Price
- ARCT $19.48
- NB $4.35
- Analyst Decision
- ARCT Strong Buy
- NB Strong Buy
- Analyst Count
- ARCT 8
- NB 2
- Target Price
- ARCT $48.83
- NB $4.50
- AVG Volume (30 Days)
- ARCT 648.4K
- NB 5.1M
- Earning Date
- ARCT 08-11-2025
- NB 09-12-2025
- Dividend Yield
- ARCT N/A
- NB N/A
- EPS Growth
- ARCT N/A
- NB N/A
- EPS
- ARCT N/A
- NB N/A
- Revenue
- ARCT $122,122,000.00
- NB N/A
- Revenue This Year
- ARCT N/A
- NB N/A
- Revenue Next Year
- ARCT $37.73
- NB N/A
- P/E Ratio
- ARCT N/A
- NB N/A
- Revenue Growth
- ARCT N/A
- NB N/A
- 52 Week Low
- ARCT $8.04
- NB $1.27
- 52 Week High
- ARCT $25.88
- NB $5.09
- Technical
- Relative Strength Index (RSI)
- ARCT 75.39
- NB 60.76
- Support Level
- ARCT $11.27
- NB $4.07
- Resistance Level
- ARCT $19.99
- NB $4.99
- Average True Range (ATR)
- ARCT 1.31
- NB 0.52
- MACD
- ARCT 0.79
- NB 0.09
- Stochastic Oscillator
- ARCT 94.15
- NB 69.80
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.
About NB NioCorp Developments Ltd.
NioCorp Developments Ltd is engaged in exploration and development of mineral deposits in North America, specifically, the Elk Creek Niobium/Scandium/Titanium property.